Heading deeper into the second half of the year, it is a good time to do a pulse check on the industry and take a step back to ask how things are actually going, and how that compares with where the industry stood a year ago. Market value is up 6% compared to Q2 2025. But underneath that number, and underneath what's changed for the patients sitting in the exam chair, the picture is more complex than a single growth figure.
A Modest Return to In-Person Shopping
Starting with eyewear purchasing itself, online eyewear buying is up slightly this year, which might suggest a market drifting further from the exam chair, but that isn’t necessarily the case. Forty-three percent of those who previously bought their eyeglasses online made their most recent purchase in person instead. The online share of eyeglasses purchases rose from 13% in Q2 2025 to 16% in Q2 2026, and in-person dipped correspondingly, from 87% to 84%. That's a real shift, but the 43% switch-back rate suggests it isn't a one-way migration. A meaningful share of the online-curious are trying it, then returning to a physical location for their next pair. For practices worried about losing patients to online retailers permanently, that's a more encouraging read.
Fewer Patients Are Falling Off the Exam Schedule—Except One Generation
Use of vision correction overall continues to inch upward, from 81% of adults in Q2 2025 to 83% in Q2 2026, and use of prescription eyewear specifically rose from 67% to 70%. The share of patients whose last eye exam was more than 2 years ago dropped from 21% to 19%. But that improvement isn't evenly distributed by generation. Gen X posted the clearest gain in recent exam rates, from 59% reporting an exam in the last year in Q2 2025 to 61% in Q2 2026, and Baby Boomers held steady at the top of the range: 68% both years. Gen Z moved in the opposite direction, dipping from 63% to 61%—the only generation to lose ground. The gap widens looking forward: Gen Z is the least likely generation to say they'll get their next exam within the coming year (73%, vs 84% for Boomers) and reports the highest share who don't plan to have an eye exam at all (9%, vs 2% for Boomers).
Buying Smaller, More Often
One of the sharper shifts is in contact lenses. In Q2 2025, half of contact lens buyers purchased a supply meant to last 3 months or less; in Q2 2026, that's risen to 58%. Overall purchase frequency held essentially flat (78% bought within the last year in 2025 vs 79% in 2026), so the same buyers appear to be purchasing in smaller batches, rather than fewer people buying overall. That could reflect price caution, a preference for flexibility, or something else entirely that might be worth a conversation during exams.
The Backdrop Worth Naming
The category-level data explain why the top-line 6% doesn't tell the whole story. Prescription glasses volume is down 6% year-over-year, but value is up 16%. Eye exam volume is down 4%, with value also up 16%. Contact lenses are the exception and a major category where rising prices haven't offset falling volume: volume is down 12% and value is down 4%. Q1 2026 was the stronger of the 2 quarters for glasses and exam value specifically; volume softened in both quarters compared to the same periods in 2025. Set against that, patients adjusting how and how much they buy, rather than whether they buy at all, tracks with an industry where price is doing more of the work than unit growth right now.
What ECPs Can Take Away
The online-to-in-person switch-back is worth surfacing with patients directly, not just tracking internally. A patient mentioning they tried buying online last time is an opening for a conversation about what in-store offerings are available that might make in-person purchasing more attractive.
The dip in overdue exams is small, but it's a good moment to reinforce recall outreach rather than assume rising costs are keeping patients away from the exam chair altogether. Recall systems and reminders built around assumptions that younger patients will self-schedule may be worth revisiting specifically for Gen Z.
Smaller, more frequent contact lens purchases may be a budgeting behavior worth asking about directly. If cost is the driver, a conversation about annual supply pricing, available rebate programs, or vision insurance benefits may head off a patient quietly reducing wear time to stretch a smaller order.
One data point ties much of this together: The eyecare provider's influence on purchase decisions has been rising, not shrinking. Eye doctor influence on prescription eyeglasses purchases climbed from 20% to 26% between 2022 and 2024, and providers already carry the highest influence of any product category on contact lens purchases specifically, at 43%. Patients switching back from an online eyewear purchase, catching up on an overdue exam, or adjusting how much contact lens supply they buy are all, in different ways, decisions where a trusted ECP's opinion still carries real weight.
Sources: The Vision Council — Market inSights; Consumer inSights Q2 2026; Consumer inSights Trended inSights (2022–2025); Provider inSights Q3–Q4 2025; Focused inSights: Consumer Choices (2024)


